Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on January 8, 2008
JNCI Journal of the National Cancer Institute 2008 100(2):155-156; doi:10.1093/jnci/djm262
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/2/155-a    most recent
djm262v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Wilkinson, G. S.
Right arrow Articles by Goodwin, J. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wilkinson, G. S.
Right arrow Articles by Goodwin, J. S.
Related Collections
Right arrowRelated Article in JNCI
Right arrowRelated Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press.

CORRESPONDENCE

Response: Re: Intravenous Bisphosphonate Therapy and Inflammatory Conditions or Surgery of the Jaw: A Population-Based Analysis

Gregg S. Wilkinson

Yong-Fang Kuo

Jean L. Freeman

James S. Goodwin

Affiliations of authors: Departments of Preventive Medicine and Community Health (GSW, YFK, JLF, JSG), Family Medicine (GSW), and Internal Medicine (YFK, JLF, JSG) and SEALY Center on Aging (GSW, YFK, JLF, JSG), University of Texas Medical Branch, Galveston, TX

Correspondence to: Gregg S. Wilkinson, PhD, Department of Preventive Medicine and Community Health, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555-1153 (e-mail: gswilkin@utmb.edu).

The first 10% of the full text of this article appears below.

We thank Khamaisi and Elad for providing us with the opportunity to further investigate and report on a risk factor that may be associated with bisphosphonate-related inflammatory conditions (including osteonecrosis) of the jaw. Khamaisi . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article in JNCI

Intravenous Bisphosphonate Therapy and Inflammatory Conditions or Surgery of the Jaw: A Population-Based Analysis
Gregg S. Wilkinson, Yong-Fang Kuo, Jean L. Freeman, and James S. Goodwin
J Natl Cancer Inst 2007 99: 1016-1024. [Abstract] [Full Text] [PDF]

Related Correspondence

Re: Intravenous Bisphosphonate Therapy and Inflammatory Conditions or Surgery of the Jaw: A Population-Based Analysis
Mogher Khamaisi and Sharon Elad
J Natl Cancer Inst 2008 100: 155. [Extract] [Full Text] [PDF]